Validation of the Neuroinflammation Cycle as a Drug Discovery Target Using Integrative Chemical Biology and Lead Compound Development with an Alzheimer's Disease-Related Mouse Model

Publisher： Bentham Science Publishers

E-ISSN： 1875-5828|2|2|197-205

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.2, Iss.2, 2005-04, pp. : 197-205

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug discovery: Estrogen-related compounds in mouse models of Alzheimer’s disease

By Smith Jonathan   Chakrabarti Enakshi   Levin-Allerhand Justine  

Journal of Molecular Neuroscience, Vol. 24, Iss. 1, 2004-02 ,pp. : 145-147

Humana Press, Inc

Access to resources Recommend Favorite

Alzheimer's disease-related synapse loss in the cingulate

By Scheff S.W.   Price D.A.  

Journal of Alzheimer's Disease, Vol. 3, Iss. 5, 2001-01 ,pp. : 495-505

Ios Press

Access to resources Recommend Favorite

Drug discovery for Alzheimer’s disease: The end of the beginning

By Refolo Lorenzo   Fillit Howard  

Journal of Molecular Neuroscience, Vol. 24, Iss. 1, 2004-02 ,pp. : 1-8

Humana Press, Inc

Access to resources Recommend Favorite

Strategies for Drug Discovery for Cognitive Aging and Alzheimer's Disease

By Fillit H.M.   O'Connell A.W.   Refolo L.M.  

Journal of Molecular Neuroscience, Vol. 19, Iss. 1-2, 2002-10 ,pp. : 1-6

Humana Press, Inc

Access to resources Recommend Favorite

Controversies in Alzheimer's disease drug development

By Cummings Jeffrey  

International Review of Psychiatry, Vol. 20, Iss. 4, 2008-08 ,pp. : 389-395

Informa Healthcare

Access to resources Recommend Favorite